Terumo Co. (OTCMKTS:TRUMY - Get Free Report) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $18.93 and traded as high as $19.73. Terumo shares last traded at $19.13, with a volume of 124,061 shares changing hands.
Terumo Trading Down 0.5 %
The company has a quick ratio of 1.72, a current ratio of 2.98 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $28.52 billion, a P/E ratio of 40.46 and a beta of 0.64. The business has a fifty day moving average price of $18.95 and a 200 day moving average price of $17.70.
Terumo (OTCMKTS:TRUMY - Get Free Report) last released its earnings results on Thursday, August 8th. The company reported $0.15 earnings per share for the quarter. The business had revenue of $1.66 billion during the quarter. On average, analysts expect that Terumo Co. will post 0.68 earnings per share for the current fiscal year.
Terumo Company Profile
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
See Also
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.